Overview of the Upcoming ASN Kidney Week Presentations Biopharma company Sobi has announced that new data will be shared at ASN Kidney Week 2025, taking place November 5–9. The conference program includes one-year efficacy data for pegylated C3G therapy pegcetacoplan (marketed as Aspaveli/Empaveli) in two glomerular diseases—the rare kidney conditions C3 glomerulopathy (C3G) and primary…